# NIOSH Pocket Guide to Chemical Hazards
Ethylene chlorohydrin | CAS 107-07-3
CH2ClCH2OH | RTECS KK0875000
Synonyms & Trade Names 2-Chloroethanol, 2-Chloroethyl alcohol, Ethylene chlorhydrin | DOT ID & Guide 1135 131
Exposure Limits | NIOSH REL: C 1 ppm (3 mg/m3) [skin]
OSHA PEL†: TWA 5 ppm (16 mg/m3) [skin]
IDLH 7 ppm | Conversion 1 ppm = 3.29 mg/m3
Physical Description Colorless liquid with a faint, ether-like odor.
MW: 80.5 | BP: 262°F | FRZ: -90°F | Sol: Miscible
VP: 5 mmHg | IP: 10.90 eV |  | Sp.Gr: 1.20
Fl.P: 140°F | UEL: 15.9% | LEL: 4.9% |
Class IIIA Combustible Liquid: Fl.P. at or above 140°F and below 200°F.
Incompatibilities & Reactivities Strong oxidizers, strong caustics, water or steam
Measurement Methods NIOSH 2513; OSHA 7
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Eyewash, Quick drench | First Aid (See procedures) Eye: Irrigate immediately Skin: Water flush immediately Breathing: Respiratory support Swallow: Medical attention immediately
Respirator Recommendations NIOSH Up to 7 ppm: (APF = 10) Any supplied-air respirator*/(APF = 50) Any self-contained breathing apparatus with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact
Symptoms Irritation mucous membrane; nausea, vomiting; dizziness, incoordination; numbness; visual disturbance; headache; thirst; delirium; low blood pressure; collapse, shock, coma; liver, kidney damage
Target Organs respiratory system, liver, kidneys, central nervous system, cardiovascular system, eyes
See also: INTRODUCTION